PDCD1 and neoplasm: For this reason, we decided to use the intratumoral injection of moronecidin (Piscidin)-like peptide in combination with anti-PD-1 inhibitors to enhance the response of primed tumor-specific T cells and prevent exhaustion by tumor cells.